Goosen TC - Search Results

1

Chemical stabilities and biological activities of thalidomide and its N-alkyl analogs.

Goosen C, Laing TJ, du Plessis J, Goosen TC, Rao TB, Flynn GL. Goosen C, et al. Among authors: goosen tc. Pharm Res. 2002 Aug;19(8):1232-5. doi: 10.1023/a:1019866730266. Pharm Res. 2002. PMID: 12240951

2

Physicochemical characterization and solubility analysis of thalidomide and its N-alkyl analogs.

Goosen C, Laing TJ, du PJ, Goosen TC, Flynn GL. Goosen C, et al. Among authors: goosen tc. Pharm Res. 2002 Jan;19(1):13-9. doi: 10.1023/a:1013643013244. Pharm Res. 2002. PMID: 11837695 Free article.

3

Percutaneous delivery of thalidomide and its N-alkyl analogs.

Goosen C, Laing TJ, du Plessis J, Goosen TC, Lu GW, Flynn GL. Goosen C, et al. Among authors: goosen tc. Pharm Res. 2002 Apr;19(4):434-9. doi: 10.1023/a:1015183310000. Pharm Res. 2002. PMID: 12033376 Free article.

4

Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide.

Varma MV, Lai Y, Kimoto E, Goosen TC, El-Kattan AF, Kumar V. Varma MV, et al. Among authors: goosen tc. Pharm Res. 2013 Apr;30(4):1188-99. doi: 10.1007/s11095-012-0956-5. Epub 2013 Jan 10. Pharm Res. 2013. PMID: 23307347

5

Physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions.

Varma MV, Lai Y, Feng B, Litchfield J, Goosen TC, Bergman A. Varma MV, et al. Among authors: goosen tc. Pharm Res. 2012 Oct;29(10):2860-73. doi: 10.1007/s11095-012-0792-7. Epub 2012 May 26. Pharm Res. 2012. PMID: 22638872

6

Response to the comment on the article "physiologically based modeling of pravastatin transporter-mediated hepatobiliary disposition and drug-drug interactions".

Varma MV, Lai Y, Feng B, Litchfield J, Goosen TC, Bergman A. Varma MV, et al. Among authors: goosen tc. Pharm Res. 2013 Jun;30(6):1469-70. doi: 10.1007/s11095-013-0987-6. Epub 2013 Mar 6. Pharm Res. 2013. PMID: 23462935 No abstract available.

7

Inactivation of cytochrome P450 2B1 by benzyl isothiocyanate, a chemopreventative agent from cruciferous vegetables.

Goosen TC, Kent UM, Brand L, Hollenberg PF. Goosen TC, et al. Chem Res Toxicol. 2000 Dec;13(12):1349-59. doi: 10.1021/tx000133y. Chem Res Toxicol. 2000. PMID: 11123978

8

Relative contributions of cytochrome CYP3A4 versus CYP3A5 for CYP3A-cleared drugs assessed in vitro using a CYP3A4-selective inactivator (CYP3cide).

Tseng E, Walsky RL, Luzietti RA Jr, Harris JJ, Kosa RE, Goosen TC, Zientek MA, Obach RS. Tseng E, et al. Among authors: goosen tc. Drug Metab Dispos. 2014 Jul;42(7):1163-73. doi: 10.1124/dmd.114.057000. Epub 2014 Apr 15. Drug Metab Dispos. 2014. PMID: 24737844

9

In Vitro Kinetic Characterization of Axitinib Metabolism.

Zientek MA, Goosen TC, Tseng E, Lin J, Bauman JN, Walker GS, Kang P, Jiang Y, Freiwald S, Neul D, Smith BJ. Zientek MA, et al. Among authors: goosen tc. Drug Metab Dispos. 2016 Jan;44(1):102-14. doi: 10.1124/dmd.115.065615. Epub 2015 Oct 28. Drug Metab Dispos. 2016. PMID: 26512042

10

Quantitative prediction of repaglinide-rifampicin complex drug interactions using dynamic and static mechanistic models: delineating differential CYP3A4 induction and OATP1B1 inhibition potential of rifampicin.

Varma MV, Lin J, Bi YA, Rotter CJ, Fahmi OA, Lam JL, El-Kattan AF, Goosen TC, Lai Y. Varma MV, et al. Among authors: goosen tc. Drug Metab Dispos. 2013 May;41(5):966-74. doi: 10.1124/dmd.112.050583. Epub 2013 Feb 7. Drug Metab Dispos. 2013. PMID: 23393219

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters